ReviewESMO open2019

European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis.

Kyriaki Tzogani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.